PIK3CA is activated through mutation in ~ 35% of cases, most of which do not show amplification of ErbB2. Thus, collectively, ERBB2/Neu+ and PIK3CAmutant breast tumors represent the majority of cases. The gene discussed is PIK3CA; the disease is breast neoplasm.